Compugen Ltd. (NASDAQ:CGEN) Q3 2023 Earnings Conference Call November 7, 2023 8:30 AM ET Company Participants Yvonne Naughton – Head-Investor Relations and Corporate Communications Anat Cohen-Dayag – President and Chief Executive Officer Alberto Sessa – Chief Financial Officer Henry Adewoye – Chief Medical Officer Pierre Ferre – Vice President-Preclinical Development Conference Call Participants Steve Willey – Stifel Operator Ladies and gentlemen, thank you for joining us today. Welcome to CompugenÂ's Third ...

Company Participants Yvonne Naughton - Head of Investor Relations and Corporate Communications Alberto Sessa - Chief Financial Officer Eran Ophir - Chief Scientific Officer Stephen Willey - Stifel Financial Corp. Tony Butler - EF Hutton Ladies and gentlemen, thank you for joining us today. Welcome to CompugenÂ's Second Quarter 2023 Results Conference Call. At this time, all participants are in a listen-only mode. As a reminder, todayÂ's call is being recorded. An audio webcast of this call will be made avai ...

We recognize the importance of cash efficiency and we are disciplined in how we deploy our cash resources, making sure we will focus on reaching key milestones with our available cash runway at least through the end of 2024. It is important to emphasize that this does not include any potential cash inflows, including potential milestones payment from our collaborator AstraZeneca. Expenses for the first quarter of 2023 were in line with our plans. R&D expenses for the first quarter of 2023 were $7.4 million, ...

Compugen Ltd. (NASDAQ:CGEN) Q4 2022 Earnings Conference Call February 23, 2023 8:30 AM ET Company Participants Yvonne Naughton - Head, IR and Corporate Communications Anat Cohen-Dayag - President and CEO Henry Adewoye - Chief Medical Officer Eran Ophir - SVP, Research and Drug Discovery Alberto Sessa - CFO Conference Call Participants Stephen Willey - Stifel Mark Breidenbach - Oppenheimer Asthika Goonewardene - Truist Securities Daina Graybosch - SVB Securities Charles Butler - EF Hutton Operator Ladies and ...

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or an emerging growth company. See definitio ...

om pugen FROM CODE TO CURE® Corporate Overview 14 November 2022 מפככפכדתכרכוכ DOCTCTCTCTCCC Safe Harbor Statement This presentation contains "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended, and the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of terminology such as "will," "may," "expects," "anticipates," "believes," "potential," "plan," ...

Compugen Ltd. (NASDAQ:CGEN) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Yvonne Naughton - Head, Investor Relations and Corporate Communications Anat Cohen-Dayag - President and Chief Executive Officer Henry Adewoye - Chief Medical Officer Eran Ophir - Senior Vice President, Research and Drug Discovery Alberto Sessa - Chief Financial Officer Conference Call Participants Stephen Willey - Stifel Mark Breidenbach - Oppenheimer Reni Benjamin - JMP Securities Daina Graybosch ...

Compugen Ltd. (NASDAQ:CGEN) Q2 2022 Earnings Conference Call August 4, 2022 8:30 AM ET Company Participants Yvonne Naughton - Head of IR and Corporate Communications Anat Cohen-Dayag - President & CEO Ari Krashin - Chief Financial & Operating Officer Henry Adewoye - Chief Medical Officer Eran Ophir - Vice President Research & Drug Discovery Conference Call Participants Bonnie Quach - Stifel Mark Breidenbach - Oppenheimer Tony Butler - Roth Capital Daina Graybosch - SVB Leerink Reni Benjamin - JMP Securities ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 _________________________________________________ FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15( ...

Compugen Ltd. (NASDAQ:CGEN) Q4 2021 Results Conference Call February 24, 2022 8:30 AM ET Company Participants Anat Cohen-Dayag - President and CEO Yvonne Naughton - Head of Investor Relations and Corporate Communications Henry Adewoye - Chief Medical Officer Ari Krashin - Chief Financial and Operating Officer Eran Ophir - Vice President Research & Drug Discovery Conference Call Participants Stephen Willey - Stifel Reni Benjamin - JMP Securities Tony Butler - ROTH Capital Daina Graybosch - SVB Leerink Operat ...